# Neural Circuit Effects of Ketamine in Depression

> **NCT06213324** · PHASE4 · RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 120 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06213324
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-31
- **Primary completion:** 2028-03-30
- **Final completion:** 2028-04-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06213324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06213324, "Neural Circuit Effects of Ketamine in Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06213324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*